Studies have demonstrated the link between the IL18 rs187238 polymorphism and increased risk of CLL in the Turkish population [101], and the rs1946518 polymorphism is linked to a risk of pediatric ALL in the Asian population [96]. This evidence concerns the gene IL18 and B-cell chronic lymphocytic leukemia.